Table 2 Demographic and clinical characteristics of study patients

Age (years)^a, mean ± SD

58.2 ± 14.6

63.3 ± 10.9

59.3 ± 14.1

56.9 ± 14.2

60.0 ± 9.7

57.5 ± 13.5

0.478

Side of the lesion^c

0.257

 Right

12*

3

15 (46.9%)

10

4

14 (66.7%)

 Left

13*

4

17 (53.1%)

7

0

7 (33.3%)

BMI^a, mean ± SD

22.3 ± 3.4

24.1 ± 3.0

22.7 ± 3.4

22.2 ± 1.9

22.1 ± 1.5

22.2 ± 1.8

0.841

Menopausal status^b

1.000

 Premenopause

6

0

6 (18.7%)

4

0

4 (19.0%)

 Postmenopause

19

7

26 (81.3%)

13

4

17 (81.0%)

Parity^b

0.384

 Multipara

21

6

27 (84.4%)

17

3

20 (95.2%)

 Nullipara

4

1

5 (15.6%)

0

1

1 (4.8%)

Clinical symptoms^a

0.380

 Asymptomatic

9

2

11 (34.4%)

3

1

4 (19.0%)

 Pelvic pain

3

1

4 (12.5%)

1

0

1 (4.8%)

 Urinary frequency

0

0

0 (0.0%)

0

1

1 (4.8%)

 Vaginal bleeding

1

1

2 (6.3%)

7

1

8 (38.1%)

 Abdominal distension /discomfort

12

3

15 (46.9%)

6

1

7 (33.3%)

Pathology

N/A

 Fibroma

6

6

12 (37.5%)

 Fibrothecoma

14

0

14 (43.8%)

 Thecoma

3

0

3 (9.4%)

 Cellular fibroma

2

1

3 (9.4%)

Adult-type GCT

 FIGO stage Ia

10

4

14 (66.7%)

 Ic

3

0

3 (14.3%)

 IIa

1

0

1 (4.8%)

 IIc

1

0

1 (4.8%)

 IIIc

2

0

2 (9.5%)